Showing results (391-400 of 509) with videos related to

Sort By:
Pageof 51
Ebiomedicine|September 30, 2023
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancerLucia De Monte, Francesca Clemente, Eliana Ruggiero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2009
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristicsStefano Crippa, Carlos Fernández-Del Castillo, Roberto Salvia, et al.
United European Gastroenterology Journal|December 6, 2024
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendationsJ Enrique Dominguez-Muñoz, Miroslav Vujasinovic, Daniel de la Iglesia, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 18, 2022
International multidisciplinary survey on the initial management of acute pancreatitis: Perspective of point-of-care specialists focused on daily practiceNuria Lluís, Horacio Asbun, Marc G Besselink, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 9, 2026
Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter studyMaria Kiriukova, Giulia Orsi, Vasile Sandru, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2013
Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cystsZheng Cao, Kevin Maupin, Bryan Curnutte, et al.
The American Journal of Gastroenterology|March 6, 2013
Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control studyGabriele Capurso, Stefania Boccia, Roberto Salvia, et al.
Endoscopy International Open|February 29, 2024
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE)Giuseppe Vanella, Giuseppe Dell'Anna, Agostino Cosenza, et al.
Cell Reports. Medicine|February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancerVeronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Biomedicine Hub|February 10, 2021
Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?Denis Horgan, Barbara Moss, Stefania Boccia, et al.
Pageof 51